ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 298

In CCP Positive “At Risk of Rheumatoid Arthritis” Individuals, the Presence of Sub-clinical Synovitis in 4-10joints Universally Results in Clinical Synovitis

Laurence Duquenne1, Kulveer Mankia 2, Jacqueline Nam 2, Andrea Di Matteo 2, Leticia Garcia-Montoya 2 and Paul Emery 2, 1Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, England, United Kingdom, 2Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

Meeting: ACR/ARP Annual Meeting 2019

Keywords: At-Risk of Inflammatory Arthritis, Doppler ultrasound and Risk Prediction

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Imaging Of Rheumatic Diseases Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: In a cohort of Anti-Cyclic Citrullinated Peptide Positive (Anti-CCP+) At-Risk of developing inflammatory arthritis (IA) individuals without clinical synovitis, previous univariable analysis showed that the presence of a Power Doppler signal (PD) in at least one joint was predictive of progression (Nam, 2016).

Further analysis is required to examine the influence of the number of joints PD positive on the progression rates and incorporate this data in the already established 2010 ACR/EULAR criteria for Rheumatoid Arthritis (RA), replacing the swollen joint count by the PD positive joint count.
Objectives:

  1. To investigate the association between the number of joints with a Power Doppler signal and progression to IA.
  2. To include the PD positive joint count in the 2010 ACR/EULAR criteria for RA to improve prediction in individuals without synovitis.

Methods: Participants were selected by an anti-CCP positive test and a new musculo-skeletal symptom. Individuals with intermittent symptoms or clinical synovitis were excluded.

Using univariable cox regression, we described for the first time the predictive value of the number of joints with a Power Doppler signal.

By replacing the number of swollen joints, with the number of joints PD positive in the 2010 ACR/EULAR criteria for RA, we then analysed IA-free survival curves for participants without clinically swollen joints.

Results: 361 patients were followed for a mean of 24 months (Table 1). Of the 28% of participants who developed IA, 81% met the ACR/EULAR criteria for RA at progression. There were significantly more participants with high anti-CCP titres in the progressor group.
Using Cox univariable analysis, the results show that the probability of developing IA is significantly increased by a Hazard ratio of 1.89 if 1 to 3 small joints present a PD signal (p=0.012), and of 3.81 if 4 to 10 joints are PD positive (p< 0.001) (Figure 1). Furthermore, all participants presenting with 4 to 10 joints progressed, 60% of them in the first 2 years (Figure 1).
Using multivariable analysis and adding CCP titre and inflammatory markers to the PD positive joint count, Hazard Ratio for the probability of progression shows a risk 2.97 times higher (p >0.001, CI 1.96-4.49) for the participants who met the 2010 ACR/EULAR criteria for RA replacing the swollen joint score with the PD positive joint count (Figure 2).

Conclusion:

  1. All of the participants with 4 to 10 joints with a Power Doppler Signal progressed to IA (mainly RA), 60% of them in the first 2 years.
  2. The predictive value for progression to IA of ultrasound scans is not improved by the addition of CCP titres and inflammatory markers (when included in the 2010 ACR/EULAR criteria for RA using Power Doppler positive joint count in patient without clinical synovitis).


Disclosure: L. Duquenne, None; K. Mankia, None; J. Nam, None; A. Di Matteo, None; L. Garcia-Montoya, None; P. Emery, AbbVie, 2, 5, 9, BMS, 2, 5, Bristol-Myers Squibb, 2, 5, 9, Gilead, 5, Lilly, 2, 5, 9, MSD, 2, 5, 9, Novartis, 2, 5, 9, Pfizer, 2, 5, 9, Roche, 2, 5, 9, Samsung, 2, 5, 9, Samsung Bioepis Co., Ltd., 2, Sandoz, 2, 5, 9, UCB, 2, 5, 9.

To cite this abstract in AMA style:

Duquenne L, Mankia K, Nam J, Di Matteo A, Garcia-Montoya L, Emery P. In CCP Positive “At Risk of Rheumatoid Arthritis” Individuals, the Presence of Sub-clinical Synovitis in 4-10joints Universally Results in Clinical Synovitis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/in-ccp-positive-at-risk-of-rheumatoid-arthritis-individuals-the-presence-of-sub-clinical-synovitis-in-4-10joints-universally-results-in-clinical-synovitis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARP Annual Meeting 2019

ACR Meeting Abstracts - https://acrabstracts.org/abstract/in-ccp-positive-at-risk-of-rheumatoid-arthritis-individuals-the-presence-of-sub-clinical-synovitis-in-4-10joints-universally-results-in-clinical-synovitis/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology